Antiverse Company

Antiverse is building a world-first computational antibody drug discovery platform to predict antibody-antigen binding and provide antibody drug candidates.

Connections from

Technology: AgeTech Companies
Industry: Healthcare
Headquarters: United Kingdom
Employees Number: 1-10
Funding Status: Seed
Investors Number: 9
Total Funding: 2413174
Estimated Revenue: $100M to $500M
Last Funding Date: 2021-03-15
Last Funding Type: Seed

Visit Website
info@antiverse.io
Register and Claim Ownership